Cargando…

Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents

Culture-based blood–brain barrier (BBB) models are crucial tools to enable rapid screening of brain-penetrating drugs. However, reproducibility of in vitro barrier properties and permeability remain as major challenges. Here, we report that self-assembling multicellular BBB spheroids display reprodu...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Choi-Fong, Wolfe, Justin M., Fadzen, Colin M., Calligaris, David, Hornburg, Kalvis, Chiocca, E. Antonio, Agar, Nathalie Y. R., Pentelute, Bradley L., Lawler, Sean E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467173/
https://www.ncbi.nlm.nih.gov/pubmed/28585535
http://dx.doi.org/10.1038/ncomms15623
_version_ 1783243219539066880
author Cho, Choi-Fong
Wolfe, Justin M.
Fadzen, Colin M.
Calligaris, David
Hornburg, Kalvis
Chiocca, E. Antonio
Agar, Nathalie Y. R.
Pentelute, Bradley L.
Lawler, Sean E.
author_facet Cho, Choi-Fong
Wolfe, Justin M.
Fadzen, Colin M.
Calligaris, David
Hornburg, Kalvis
Chiocca, E. Antonio
Agar, Nathalie Y. R.
Pentelute, Bradley L.
Lawler, Sean E.
author_sort Cho, Choi-Fong
collection PubMed
description Culture-based blood–brain barrier (BBB) models are crucial tools to enable rapid screening of brain-penetrating drugs. However, reproducibility of in vitro barrier properties and permeability remain as major challenges. Here, we report that self-assembling multicellular BBB spheroids display reproducible BBB features and functions. The spheroid core is comprised mainly of astrocytes, while brain endothelial cells and pericytes encase the surface, acting as a barrier that regulates transport of molecules. The spheroid surface exhibits high expression of tight junction proteins, VEGF-dependent permeability, efflux pump activity and receptor-mediated transcytosis of angiopep-2. In contrast, the transwell co-culture system displays comparatively low levels of BBB regulatory proteins, and is unable to discriminate between the transport of angiopep-2 and a control peptide. Finally, we have utilized the BBB spheroids to screen and identify BBB-penetrant cell-penetrating peptides (CPPs). This robust in vitro BBB model could serve as a valuable next-generation platform for expediting the development of CNS therapeutics.
format Online
Article
Text
id pubmed-5467173
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-54671732017-06-19 Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents Cho, Choi-Fong Wolfe, Justin M. Fadzen, Colin M. Calligaris, David Hornburg, Kalvis Chiocca, E. Antonio Agar, Nathalie Y. R. Pentelute, Bradley L. Lawler, Sean E. Nat Commun Article Culture-based blood–brain barrier (BBB) models are crucial tools to enable rapid screening of brain-penetrating drugs. However, reproducibility of in vitro barrier properties and permeability remain as major challenges. Here, we report that self-assembling multicellular BBB spheroids display reproducible BBB features and functions. The spheroid core is comprised mainly of astrocytes, while brain endothelial cells and pericytes encase the surface, acting as a barrier that regulates transport of molecules. The spheroid surface exhibits high expression of tight junction proteins, VEGF-dependent permeability, efflux pump activity and receptor-mediated transcytosis of angiopep-2. In contrast, the transwell co-culture system displays comparatively low levels of BBB regulatory proteins, and is unable to discriminate between the transport of angiopep-2 and a control peptide. Finally, we have utilized the BBB spheroids to screen and identify BBB-penetrant cell-penetrating peptides (CPPs). This robust in vitro BBB model could serve as a valuable next-generation platform for expediting the development of CNS therapeutics. Nature Publishing Group 2017-06-06 /pmc/articles/PMC5467173/ /pubmed/28585535 http://dx.doi.org/10.1038/ncomms15623 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Cho, Choi-Fong
Wolfe, Justin M.
Fadzen, Colin M.
Calligaris, David
Hornburg, Kalvis
Chiocca, E. Antonio
Agar, Nathalie Y. R.
Pentelute, Bradley L.
Lawler, Sean E.
Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents
title Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents
title_full Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents
title_fullStr Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents
title_full_unstemmed Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents
title_short Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents
title_sort blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467173/
https://www.ncbi.nlm.nih.gov/pubmed/28585535
http://dx.doi.org/10.1038/ncomms15623
work_keys_str_mv AT chochoifong bloodbrainbarrierspheroidsasaninvitroscreeningplatformforbrainpenetratingagents
AT wolfejustinm bloodbrainbarrierspheroidsasaninvitroscreeningplatformforbrainpenetratingagents
AT fadzencolinm bloodbrainbarrierspheroidsasaninvitroscreeningplatformforbrainpenetratingagents
AT calligarisdavid bloodbrainbarrierspheroidsasaninvitroscreeningplatformforbrainpenetratingagents
AT hornburgkalvis bloodbrainbarrierspheroidsasaninvitroscreeningplatformforbrainpenetratingagents
AT chioccaeantonio bloodbrainbarrierspheroidsasaninvitroscreeningplatformforbrainpenetratingagents
AT agarnathalieyr bloodbrainbarrierspheroidsasaninvitroscreeningplatformforbrainpenetratingagents
AT pentelutebradleyl bloodbrainbarrierspheroidsasaninvitroscreeningplatformforbrainpenetratingagents
AT lawlerseane bloodbrainbarrierspheroidsasaninvitroscreeningplatformforbrainpenetratingagents